Eli Lilly & Co.
LLY XNYS
$1133.00
-28.95 (-2.49%)
▼
15-min delayed
Open
$1165.00
High
$1169.99
Low
$1132.81
Volume
2.40M
Market Cap
$1.04T
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Key Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| TTM 2025 | $65.18B | $20.64B | $23.00 |
| FY 2025 | $65.18B | $20.64B | $23.00 |
| Q3 2025 | $17.60B | $5.58B | $6.22 |
| Q2 2025 | $15.56B | $5.66B | $6.30 |
TickerDaily Coverage
Why Are Stock Market Movers Up Today? Top 5 Pre-Market Leaders Before the Bell (May 28, 2026)
Market News
Sarah Mitchell · May 28, 2026
Five stocks are making massive pre-market moves this morning ahead of Thursday's open. We break...
Why Are These Top Stocks Up and Down Before the Bell on April 30, 2026?
Market News
Sarah Mitchell · Apr 30, 2026
Several major stocks are making significant moves in pre-market trading on Thursday, April 30,...
Why Are These 5 Stocks Making Biggest Pre-Market Moves Today? April 7, 2026
Market News
Sarah Mitchell · Apr 7, 2026
Tuesday's pre-market session is already volatile. Five major stocks are moving significantly on...
View All Coverage →
Get LLY Alerts
Stay ahead with breaking news, price alerts, and expert analysis on Eli Lilly & Co..
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.